7th Jan 2022 14:47
Oxford Nanopore Technologies PLC - Oxford, England-based genomics firm specialising in DNA sequencing - Expects to report core Life Science Research Tools revenue of above GBP120 million, up 83% from LSRT revenue of GBP65.5 million the year prior.
Adds that this also exceeds previously given guidance of GBP105 to GBP111 million. Expects to report total revenue of GBP126 million, increased 11% from total revenue of GBP113.9 million the year before. States that all other previously given guidance remains unchanged.
Current stock price: 614.00 pence, up 0.2% on Friday
12-month change: down 12%
By Abby Amoakuh; [email protected]
Copyright 2022 Alliance News Limited. All Rights Reserved.
Related Shares:
Oxford Nano